{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:06:50Z","timestamp":1787843210020,"version":"build-2784847793"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.humimm.2016.11.003","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T00:33:38Z","timestamp":1479256418000},"page":"72-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Root cause analysis of limitations of virtual crossmatch for kidney allocation to highly-sensitized patients"],"prefix":"10.1016","volume":"78","author":[{"given":"Vivek","family":"Jani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ingulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Mekeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald P.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2016.11.003_b0005","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0198-8859(99)00121-4","article-title":"Flow cytometric detection of HLA antibodies using a spectrum of microbeads","volume":"60","author":"Pei","year":"1999","journal-title":"Human Immunol."},{"key":"10.1016\/j.humimm.2016.11.003_b0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00007890-200301150-00008","article-title":"Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities","volume":"75","author":"Pei","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.11.003_b0015","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2016.11.003_b0020","first-page":"277","article-title":"Crossmatching with B and T cells and flow cytometry","volume":"1","author":"Iwaki","year":"1986","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.humimm.2016.11.003_b0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-6143.2009.02927.x","article-title":"Calculated PRA (CPRA): the new measure of sensitization for transplant candidates","volume":"10","author":"Cecka","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1399-3046.2005.00394.x","article-title":"The virtual crossmatch\u2013a screening tool for sensitized pediatric heart transplant recipients","volume":"10","author":"Zangwill","year":"2006","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0035","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1111\/j.1600-6143.2006.01521.x","article-title":"Transplanting the highly sensitized patient: the emory algorithm","volume":"6","author":"Bray","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0040","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1600-6143.2010.03340.x","article-title":"Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches","volume":"11","author":"Cecka","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.humimm.2016.03.003","article-title":"CPRA for allocation of kidneys in the US: more candidates \u2a7e98% CPRA, lower positive crossmatch rates and improved transplant rates for sensitized patients","volume":"77","author":"Baxter-Lowe","year":"2016","journal-title":"Human Immunol."},{"issue":"S2","key":"10.1016\/j.humimm.2016.11.003_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ajt.13195","article-title":"OPTN\/SRTR 2013 annual data report: kidney","volume":"15","author":"Matas","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0055","article-title":"Early changes in kidney distribution under the new allocation system","volume":"17","author":"Massie","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.humimm.2016.11.003_b0060","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/ajt.13770","article-title":"Changes in deceased donor kidney transplantation one year after KAS implementation","volume":"16","author":"Stewart","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0065","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1600-6143.2009.02724.x","article-title":"Perception versus reality?: virtual crossmatch\u2013how to overcome some of the technical and logistic limitations","volume":"9","author":"Tambur","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0070","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.humimm.2010.01.003","article-title":"Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation","volume":"71","author":"Morris","year":"2010","journal-title":"Human Immunol."},{"key":"10.1016\/j.humimm.2016.11.003_b0075","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-6143.2007.01667.x","article-title":"Pretransplant risk assessment in renal allograft recipients using virtual crossmatching","volume":"7","author":"Bielmann","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0080","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1097\/TP.0b013e318191404c","article-title":"A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation","volume":"86","author":"Bingaman","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.11.003_b0085","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/ajt.12734","article-title":"Center-defined unacceptable HLA antigens facilitate transplants for sensitized patients in a multi-center kidney exchange program","volume":"14","author":"Baxter-Lowe","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0090","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/ajt.13606","article-title":"Renal transplantation with final allocation based on the virtual crossmatch","volume":"16","author":"Johnson","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0095","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/ajt.13381","article-title":"Unintended consequences of the new national kidney allocation policy in the United States","volume":"15","author":"Tambur","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0100","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.transproceed.2014.07.053","article-title":"Virtual crossmatch in kidney transplantation","volume":"46","author":"Piazza","year":"2014","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.humimm.2016.11.003_b0105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.humimm.2012.04.016","article-title":"Cutoff values and data handling for solid-phase testing for antibodies to HLA: effects on listing unacceptable antigens for thoracic organ transplantation","volume":"73","author":"Liu","year":"2012","journal-title":"Human Immunol."},{"key":"10.1016\/j.humimm.2016.11.003_b0110","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.humimm.2012.04.007","article-title":"Diagnostic accuracy of solid phase HLA antibody assays for prediction of crossmatch strength","volume":"73","author":"Ellis","year":"2012","journal-title":"Human Immunol."},{"key":"10.1016\/j.humimm.2016.11.003_b0115","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.humimm.2011.02.012","article-title":"Donor-specific antibody against denatured HLA-A1: clinically nonsignificant?","volume":"72","author":"Pereira","year":"2011","journal-title":"Human Immunol."},{"key":"10.1016\/j.humimm.2016.11.003_b0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trim.2011.05.007","article-title":"Positive virtual crossmatch with negative flow crossmatch results in two cases","volume":"25","author":"Jacob","year":"2011","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.humimm.2016.11.003_b0125","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.humimm.2009.04.001","article-title":"Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution","volume":"70","author":"Zachary","year":"2009","journal-title":"Human Immunol."},{"key":"10.1016\/j.humimm.2016.11.003_b0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.trim.2013.09.005","article-title":"The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients","volume":"29","author":"Guidicelli","year":"2013","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.humimm.2016.11.003_b0135","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.TP.0000441091.47464.c6","article-title":"Complement component C3 activation: the leading cause of the prozone phenomenon affecting HLA antibody detection on single-antigen beads","volume":"97","author":"Schwaiger","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.11.003_b0140","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/ajt.13295","article-title":"Assessing antibody strength: comparison of MFI, C1q, and titer information","volume":"15","author":"Tambur","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0145","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/TP.0b013e31822872dd","article-title":"HLA antibody specification using single-antigen beads\u2013a technical solution for the prozone effect","volume":"92","author":"Schnaidt","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.11.003_b0150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humimm.2012.10.012","article-title":"Modified solid-phase alloantibody detection for improved crossmatch prediction","volume":"74","author":"Wahrmann","year":"2013","journal-title":"Human Immunol."},{"key":"10.1016\/j.humimm.2016.11.003_b0155","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa067160","article-title":"Antibodies against MICA antigens and kidney-transplant rejection","volume":"357","author":"Zou","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2016.11.003_b0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.11.003_b0165","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/TP.0b013e3181a5e034","article-title":"Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads","volume":"87","author":"Amico","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.11.003_b0170","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2011.03640.x","article-title":"Revisiting traditional risk factors for rejection and graft loss after kidney transplantation","volume":"11","author":"Dunn","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0175","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2009.02985.x","article-title":"Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation","volume":"10","author":"Gloor","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0180","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1600-6143.2011.03985.x","article-title":"Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure","volume":"12","author":"Otten","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.11.003_b0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.trim.2013.07.002","article-title":"Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?","volume":"29","author":"Crespo","year":"2013","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.humimm.2016.11.003_b0190","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/TP.0000000000000203","article-title":"Determinants of C1q binding in the single antigen bead assay","volume":"98","author":"Schaub","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.11.003_b0195","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1432-2277.2011.01235.x","article-title":"Risk stratification by the virtual crossmatch: a prospective study in 233 renal transplantations","volume":"24","author":"Amico","year":"2011","journal-title":"Transpl. Int."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916304967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916304967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T17:56:57Z","timestamp":1536256617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885916304967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0198885916304967"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2016.11.003","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Root cause analysis of limitations of virtual crossmatch for kidney allocation to highly-sensitized patients","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2016.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}